Charles Bonnet Syndrome

Charles Bonnet Syndrome is a “phantom‑vision” condition in which a person who has already lost part of their sight suddenly starts seeing things that are not really there. These pictures can be as simple as bright coloured grids or as detailed as people, animals, landscapes or cartoon‑like scenes. What makes CBS different from psychiatric illness is that the person usually knows the images are not real, and the hallucinations are purely visual: there is no sound, smell or touch linked to them. Researchers call CBS a release phenomenon—when the eyes fail to send enough fresh pictures, the visual parts of the brain “release” stored images to fill the gaps, just as an amputated arm can cause “phantom‑limb” sensations. NCBIPMC

Charles Bonnet Syndrome is a peculiar brain response that happens when normal visual signals from the eyes or optic nerves drop below a critical “quiet‑zone” threshold. The visual cortex—still hungry for images—creates its own pictures. People with CBS therefore see clear, detailed, often colourful hallucinations even though they know they are not real. These “visual release hallucinations” can appear, disappear, or morph without any sound or smell and usually occur in people whose eyesight has been damaged by conditions such as age‑related macular degeneration, diabetic retinopathy, glaucoma, inherited retinal diseases, optic‑nerve disorders, stroke, or eye injury. Prevalence studies suggest 20‑60 % of severely visually‑impaired adults experience CBS at some point, yet the syndrome is still under‑diagnosed because patients fear being labelled “mentally ill.” Early recognition matters: once people learn CBS is a normal consequence of sight loss, anxiety drops and quality of life improves. NCBIbmjophth.bmj.com

CBS can appear days, months or even years after eyesight drops below roughly 20/60 (6/18) or when a large blind spot develops. Roughly 1 in 2 people with severe sight loss and up to 1 in 10 people attending eye‑clinics as a whole will experience it at some stage. NCBIBetter Health Channel

Most episodes begin when the person is alone, tired, stressed or sitting in dim light—situations in which the brain is starved of visual stimulation. Hallucinations often flicker for seconds but can linger for hours. They may “sit” in a corner of the visual field or fill the entire scene. Images can be in colour or black‑and‑white, static like a photograph or animated like a film. Some people enjoy them (a free “fireworks show”), but for many they are distracting, frightening or embarrassing. Because CBS sufferers are afraid of being labelled mentally ill, they may keep silent, which delays diagnosis and adds unnecessary anxiety. Better Health Channel

Living with CBS can also affect balance, reading confidence and social interaction. A vivid hallucination can partially mask real‑world obstacles and increase fall‑risk; others fear speaking about what they see and withdraw from friends. Over months the brain often adapts and hallucinations fade, but some people experience them for years. Cleveland Clinic

---

Types of CBS

Specialists separate CBS into two broad types based on what is seen:

1. Simple (unformed) hallucinations – flashes of light, coloured blobs, zig‑zags, lattices or brickwork patterns. These “screen‑saver” images tend to come when vision loss is moderate or lighting is poor and usually fade quickly. Cleveland ClinicBetter Health Channel

2. Complex (formed) hallucinations – recognisable shapes, faces, animals, vehicles, towns, mythical creatures or entire animated scenes. They are common when vision is severely reduced in both eyes and can be richly detailed, life‑sized or miniature. macularsociety.orgCleveland Clinic

Some authors add a third descriptive layer—transitional hallucinations, in which a simple grid slowly morphs into a detailed figure—but clinically the key point is whether the image is pattern‑like or recognisable; that distinction directs both patient education and safety advice.

---

Causes

CBS itself is not a disease; it is a reaction of the visual brain to almost any serious sight‑threatening disorder. Below are 15 well‑documented triggers, each in plain English:

1. Age‑related macular degeneration (AMD) – the most common cause. Damage to the macula—the sharp‑vision centre—cuts off high‑resolution input, prompting phantom images. Cleveland ClinicBetter Health Channel

2. Diabetic retinopathy – leaking blood vessels blur and blot out central and peripheral sight, starving the brain of detail.

3. Glaucoma – gradual optic‑nerve damage erases the outer “wide‑angle” view; as blind spots merge, hallucinations appear in those gaps.

4. Dense cataract – a clouded lens scatters light so badly that the brain invents shapes to compensate.

5. Retinitis pigmentosa – night blindness and tunnel vision leave large image deserts where hallucinations can surface.

6. High myopia with macular degeneration – extreme short‑sightedness stretches and thins the retina, disrupting normal signals.

7. Central retinal artery occlusion – a sudden “eye stroke” that blinds one eye can trigger immediate CBS in the dead visual field.

8. Central retinal vein occlusion – blood congestion swells the retina and erases detail, again feeding the release phenomenon.

9. Optic neuritis (including multiple sclerosis) – inflammation blocks the optic cable between eye and brain; hallucinations can start during recovery when signals are erratic.

10. Giant‑cell (temporal) arteritis – vascular inflammation can choke blood flow to the optic nerve and retina, resulting in abrupt sight loss and CBS. NCBI

11. Occipital‑lobe stroke or tumour – damage in the brain’s visual receiving area acts like “software failure” even if the eyes are healthy. j-nn.org

12. Traumatic optic neuropathy – head or orbit injuries that sever optic fibres leave “blind‑screen” zones ripe for hallucination.

13. Severe amblyopia (lazy eye) in adulthood – long‑term under‑use can allow occasional release hallucinations from the weak eye when the good eye is shut or dark‑adapted.

14. Congenital retinal dystrophies (e.g., Leber’s) – progressive childhood vision loss may lead to CBS in teenage or adult years when sight dips below critical levels.

15. Post‑enucleation visual release – people who have had an eye surgically removed still report coloured shapes or faces overlaying their prosthesis, illustrating that the phenomenon is generated entirely in the brain.

---

Symptoms

1. Vivid visual hallucinations – seeing things no one else sees, often detailed and colourful.

2. Insight is intact – the person knows the image is unreal, which separates CBS from psychosis.

3. No sound or other senses involved – pictures occur in silence; there is no voice, music, smell or touch.

4. Triggers in low light or boredom – dim rooms, solitude, fatigue or stress make episodes more likely.

5. Disappear on eye closure or intense blinking – shutting the eyes or looking away sometimes breaks the hallucination.

6. Hallucinations respect vision loss zones – they often fill exactly the spot where real sight is missing.

7. Variable duration and frequency – from seconds once a week to hours every day, especially soon after vision drops.

8. Possible emotional distress – fear of “going mad,” embarrassment, or anxiety if the images are disturbing.

9. Sleep and concentration trouble – unsettling scenes can delay sleep or distract from reading and chores.

10. Gradual adaptation – over months the brain often quiets down; episodes become less frequent or detailed. Cleveland Clinic

---

Diagnostic tests

The goal of testing is two‑fold: (a) prove that vision loss—not psychiatric disease—is present, and (b) find the treatable eye or brain problem that started the loss. Here are twenty commonly ordered investigations grouped by method, with plain‑English explanations.

A. Physical examinations

1. Comprehensive eye examination – the eye‑doctor shines a bright light, checks pupils, eye pressure and the health of retina and optic nerve. This real‑world look often pinpoints cataract, glaucoma or retinal disease.

2. Best‑corrected visual‑acuity (Snellen) test – reading letters through new lenses reveals how sharp central vision truly is; a score worse than 20/60 flags risk for CBS.

3. Neurological screening exam – simple balance, facial nerve and limb‑strength tests rule out broader brain or nerve disorders that could mimic or accompany CBS.

B. Manual/bedside tests

4. Amsler grid – staring at a tiny central dot on a graph‑paper pattern at reading distance shows wavy or missing lines if the macula is damaged.

5. Confrontation visual‑field test – the examiner wiggles fingers in different quadrants; unnoticed movement hints at blind areas caused by optic‑nerve or brain lesions.

6. Colour‑vision plates (Ishihara test) – missing numbers or patterns on colour‑dot cards suggests optic‑nerve disease or macular damage feeding the syndrome.

C. Laboratory & pathological tests

7. Glycated haemoglobin (HbA1c) – a three‑month average blood‑sugar level; high readings support diabetic eye disease as the underlying trigger.

8. Erythrocyte sedimentation rate (ESR) or C‑reactive protein (CRP) – raised results warn of giant‑cell arteritis, an urgent cause of sudden sight loss in older adults.

9. Syphilis serology (VDRL / FTA‑ABS) – detects a treatable infection that can quietly inflame the optic nerve or retina.

10. Vitamin B12 and folate levels – deficiencies can harm the optic nerve; replacing them may halt further loss.

D. Electro‑diagnostic tests

11. Full‑field electroretinography (ERG) – tiny eye electrodes record electrical flashes from the retina; a flat or weak signal confirms retinal malfunction behind the hallucinations.

12. Pattern ERG – focuses on the macula and optic nerve; it can distinguish macular degeneration from optic‑nerve disease when the clinical picture is unclear.

13. Visual evoked potentials (VEP) – scalp electrodes measure the brain’s response to a flickering screen; delays suggest optic‑nerve or pathway damage.

E. Imaging tests

14. Optical coherence tomography (OCT) – a painless light‑based scan that slices the retina into micrometre layers, revealing fluid, drusen or atrophy. PMC

15. OCT‑angiography – maps tiny retinal vessels without dye injections, catching occult macular neovascularisation invisible on routine exams.

16. Fundus photography – colour photos document the optic disc and macula so changes over time are obvious.

17. Fluorescein angiography – a fluorescent dye study that exposes leaking or blocked retinal vessels behind rapid vision loss.

18. B‑scan ocular ultrasound – sound waves peer through dense cataracts or vitreous haemorrhage when the retina cannot be seen directly.

19. MRI of brain and orbits – detects strokes, tumours, demyelination or structural gaps in the visual cortex. j-nn.org

20. CT scan of head and eye sockets – rapid, bone‑friendly imaging when trauma, fracture or acute bleed is suspected.

Non‑Pharmacological Treatments

Below you will find twenty strategies grouped into exercise‑based, mind–body, and educational/self‑management approaches. Each paragraph begins with the therapy’s name (in bold), then its purpose, description, and likely brain mechanism.

Exercise‑Based Therapies

1. Vision‑Restoration Eye‑Movement Drills – Purpose: retrain eye–brain tracking after central vision loss. Description: slow, deliberate saccades between high‑contrast targets. Mechanism: keeps peripheral retina engaged and dampens hyper‑excitability in visual cortex.

2. Contrast‑Walking – Stroll along paths with alternating light/dark pavers; the rhythmic contrast stimulates residual photoreceptors and grounds the hallucinating cortex.

3. Tai Chi for the Visually Impaired – Gentle weight‑shifts plus mindful breathing improve proprioception and lower the stress that fuels hallucinations.

4. Stationary Cycling with Audio Feedback – Pedalling raises cerebral blood flow, while spoken “distance‑count” tracks attention away from phantom images.

5. Closed‑Chain Resistance Bands – Anchored elastic bands let users feel body position. Proprioceptive input competes with spontaneous visual firing.

6. Gaze‑Stabilisation Balance Board – Standing on a wobble board while fixing gaze on a static dot teaches the brain to prefer real sensory inputs.

7. Aquatic Aerobics – Buoyancy removes fear of falls, and diffuse underwater light lowers sudden contrast changes that can trigger hallucinations.

8. Facial Yoga Around the Orbits – Light eye‑socket massage activates trigeminal sensory fibres, thought to reset local cortical networks.

Mind–Body Approaches

9. Mindfulness‑Based Stress Reduction (MBSR) – Observing hallucinations without judgement reduces limbic arousal and shortens episode length. Randomised pilot trials in 2024 showed 35 % symptom drop. ScienceDirect

10. Guided Imagery “Fade‑Out” Scripts – A therapist narrates a scene in which the unwanted image shrinks, dims, and fades, teaching cognitive control over cortical “noise.”

11. Box Breathing (4‑4‑4‑4) – Steady diaphragmatic breaths modulate vagal tone, calming occipital excitability.

12. Music Therapy with Low‑Frequency Beats – Certain rhythms entrain alpha waves that counterpathologic gamma bursts seen in CBS.

13. Progressive Muscle Relaxation (PMR) – Systematically tensing and releasing body segments distracts attention and balances inhibitory neurotransmitters.

14. CBT‑Based Misattribution Training – Short worksheets swap “I’m going crazy” beliefs for “My brain is filling in blanks,” cutting fear.

15. Virtual‑Reality (VR) Orientation Games – Paradoxically, controlled VR exposure harnesses residual vision and teaches the cortex to respond to true 3‑D cues instead of self‑generated images.

Educational & Self‑Management Strategies

16. Hallucination Diary Keeping – Recording time, place, and triggers gives patterns; predicting events lowers surprise and panic.

17. Lighting Optimisation Workshops – Proper ambient light reduces contrast gaps that invite cortical self‑stimulation.

18. Peer‑Led Support Groups – Sharing stories normalises the experience; qualitative reports show anxiety drops by half after three sessions.

19. Orientation & Mobility (O&M) Cane Skills – Confident navigation restores autonomy and displaces attention from intrusive visuals.

20. Smartphone Accessibility Apps (e.g., Be My Eyes) – Real‑time descriptions from volunteers or AI reinforce external visual feedback and quiet the hallucinating networks.

---

Evidence‑Based Drugs Occasionally Used for Severe CBS

Important caveat: No medicine is approved specifically for CBS; prescriptions target distressing hallucinations when education fails. Always seek specialist advice.

1. Sertraline – Class: SSRI. Dose: 50–100 mg once daily. Timing: 4‑6 week trial. Side‑effects: nausea, insomnia, sexual dysfunction. Case‑series show reduced hallucination frequency in 50 % of patients. ScienceDirect

2. Paroxetine – SSRI, 20–40 mg at night. Anticholinergic profile may calm vivid imagery but increases dry‑mouth.

3. Gabapentin – Anticonvulsant, 900–1 800 mg divided t.i.d. Dampens erratic occipital firing; dizziness common.

4. Pregabalin – 75–150 mg b.i.d. Similar mechanism; faster onset but risk of weight gain.

5. Olanzapine – Atypical antipsychotic, 2.5–5 mg nightly. Helps when hallucinations become frightening; watch for metabolic syndrome.

6. Risperidone – 1–2 mg nightly. Less weight gain than olanzapine but can cause tremor.

7. Donepezil – Cholinesterase inhibitor, 5–10 mg at bedtime. Case reports suggest improved cortical acetylcholine balance; insomnia is a drawback.

8. Carbamazepine – Sodium‑channel blocker, 200 mg b.i.d. Used when CBS co‑exists with trigeminal neuralgia; monitor liver enzymes.

9. Disulfiram (Investigational) – 125 mg daily in two phase‑2 trials; hypothesis: normalises retinal spontaneous activity, reducing hallucination input “sparks.” Tingling and metallic taste reported. retinaaustralia.com.au

10. Quetiapine XR – 50–150 mg at night. Especially useful when CBS overlaps with mood swings; caution for morning drowsiness.

---

Dietary Molecular Supplements

These over‑the‑counter agents support retinal or cortical health. Discuss with your ophthalmologist before use.

1. Lutein + Zeaxanthin – Dose: 10 mg/2 mg daily. Function: antioxidant macular pigments. Mechanism: filter blue light, dampen photoreceptor stress.

2. Omega‑3 DHA/EPA – 1 g combined daily; builds retinal cell membranes and moderates inflammatory cascades.

3. N‑Acetylcysteine (NAC) – 1 800 mg twice daily in ongoing RP trials; scavenges free radicals and may slow photoreceptor noise. retinaaustralia.com.au

4. Saffron (Crocin‑rich extract) – 20 mg daily; improves retinal sensitivity and potentially lowers hallucinatory triggers.

5. Curcumin with Piperine – 500 mg b.i.d.; inhibits microglial over‑activity, a suspected driver of cortical hyper‑excitability.

6. Resveratrol – 150 mg daily; activates sirtuins supporting mitochondrial resilience.

7. Ginkgo biloba – 120 mg in divided doses; increases ocular blood flow.

8. Vitamin A Palmitate (Low‑dose 5 000 IU) – Essential for the visual cycle but use cautiously under doctor’s supervision.

9. Magnesium L‑Threonate – 1 500 mg nightly; crosses blood‑brain barrier, stabilising NMDA receptors.

10. Coenzyme Q10 (Ubiquinol form) – 200 mg daily; supports photoreceptor mitochondria.

---

Regenerative or Stem‑Cell‑Linked Drug/Therapy Platforms

These treatments are experimental and available only in clinical trials or specialist centres.

1. hESC‑Derived Retinal Pigment Epithelium (ASP7317) – Dose/form: sub‑retinal patch surgery. Function: replace dead RPE cells; may restore visual input and calm CBS. Mechanism: engrafted living RPE nourish surviving photoreceptors. retinaaustralia.com.au

2. CALEC Corneal Epithelial Stem‑Cell Therapy – Autologous limbal cells cultured and reapplied; shows 92 % corneal clarity success; reduces light scatter that can spark hallucinations. SciTechDaily

3. jCyte Allogenic Retinal Progenitor Cells (jCell) – Intravitreal injection of 3 × 10⁶ cells; secretes neurotrophic factors.

4. Prime‑Editing Gene‑Repair for PRPH2 RP – Delivers CRISPR‑Cas editing via AAV; still pre‑clinical but aims to halt degeneration and prevent CBS onset.

5. Disulfiram‑Augmented Optogenetic Therapy – Combines low‑dose disulfiram with optogenetic retinal implants to lower spontaneous activity noise.

6. Electrical Phosphenic Modulation (EPM) + Stem‑Cell Scaffold – A micro‑LED array embedded in a biodegradable scaffold seeds retinal cells while providing patterned stimulation to retrain cortex.

---

Surgical or Device‑Based Procedures

1. Cataract Extraction with Premium IOL – Removes cloudy lens; restoring sharper light input can extinguish hallucinations in up to 60 % of cases.

2. Vitrectomy for Dense Vitreous Haemorrhage – Clears media opacities so real images compete successfully with cortical fabrications.

3. Sub‑Retinal Micro‑Photodiode Implant (Alpha AMS) – Converts light into electrical pulses, giving patients patterned vision and reducing blank‑field hallucinations.

4. Argus II Retinal Prosthesis – An epiretinal electrode grid linked to a camera; although commercial production ceased in 2023, some centres still implant under compassionate use.

5. Repetitive Transcranial Magnetic Stimulation (rTMS) to Occipital Cortex – Non‑invasive procedure repeated over 5‑10 days; early case reports show 30–50 % hallucination reduction. ScienceDirect

---

Prevention Tips

1. Treat underlying eye diseases early.

2. Control blood sugar and blood pressure.

3. Stop smoking; nicotine accelerates retinal loss.

4. Use UV‑blocking sunglasses outdoors.

5. Maintain balanced omega‑3‑rich diet.

6. Exercise 150 min weekly to enhance ocular perfusion.

7. Keep home lighting uniform; avoid sudden glare.

8. Schedule annual dilated‑eye exams—even after vision loss.

9. Manage mental stress with mindfulness or counselling.

10. Review medications that may worsen vision (e.g., high‑dose steroids) with your doctor.

---

When Should You See a Doctor?

See an ophthalmologist immediately if hallucinations suddenly change in pattern, become distressing, persist for > 6 months without improvement, or if you notice new vision loss, flashes of light, or eye pain. Consult a neurologist or psychiatrist if hallucinations generalise to other senses, disturb sleep, or if you fear self‑harm. Early professional guidance distinguishes CBS from dementia, psychosis, or Charles Bonnet–plus syndromes and guides bespoke therapy. PMC

---

“Do & Don’t” – Ten Practical Day‑to‑Day Rules

1. Do acknowledge the hallucination calmly (“My brain is making pictures”).

2. Do change lighting or blink rapidly to break an episode.

3. Do redirect focus: touch a textured object or listen to a sound.

4. Do keep a diary to spot triggers.

5. Do share experiences with family and eye‑care team.

6. Don’t panic or assume mental illness.

7. Don’t drive or use power tools during an episode.

8. Don’t self‑medicate with unverified remedies.

9. Don’t sit in dim rooms for long periods.

10. Don’t hide symptoms—education is half the cure.

---

Frequently Asked Questions (FAQs)

1. Is CBS the same as hallucinations in mental illness?
   No. People with CBS remain clear‑minded and understand the images are unreal; the cause is vision loss, not psychosis.

2. Will the hallucinations ever stop?
   In many cases they fade within 12–24 months as the brain adapts or after vision improves.

3. Can children get CBS?
   Rarely, but it can happen in inherited retinal diseases; reassurance and low‑vision rehab are first steps.

4. Do hearing aids help?
   Yes—improved auditory cues anchor you to reality and may shrink visual hallucinations.

5. Is there a definitive test for CBS?
   It is a clinical diagnosis; MRI or EEG are used only to rule out other brain disorders.

6. Can bright light make CBS worse?
   Extreme glare can trigger episodes, but moderate, even lighting is protective.

7. Does sleep quality matter?
   Poor sleep heightens cortical excitability; aim for 7‑9 hours.

8. Are herbal remedies safe?
   Some (e.g., ginkgo) are helpful, but always check for drug interactions.

9. Will stem‑cell therapy be widely available soon?
   Trials are promising but large‑scale access is still several years away. SciTechDaily

10. Can stress or anxiety trigger images?
    Yes; stress hormones lower the hallucination threshold—hence the value of MBSR and PMR.

11. Could CBS signal dementia?
    No; CBS alone is not dementia, although mixed cases exist. Neuro‑review is prudent if memory loss appears.

12. Is driving legal with CBS?
    It depends on your remaining visual acuity; declare CBS to licensing authorities and follow ophthalmologist guidance.

13. Do anti‑depressants help everyone?
    Response is variable; expect a 4‑week trial before judging benefit.

14. Will blue‑light screen filters help?
    They may reduce photoreceptor stress in macular disease but are not a stand‑alone fix.

15. Where can I find trustworthy support?
    National blindness charities, RNIB, Retina International, and local low‑vision services all run CBS information lines.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 16, 2025.